Cargando…

Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial

This study seeks to investigate potential cardioprotection of Danlou Tablets in patients undergoing PCI with non-ST elevation acute coronary syndrome (NSTE-ACS). 219 patients with NSTE-ACS were randomised to Danlou Tablet pretreatment (n = 109) or placebo (n = 110). No patients received statins prio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Zhao, Xujie, Mao, Shuai, Liu, Shaonan, Guo, Xinfeng, Guo, Liheng, Du, Tinghai, Yang, Haiyu, Zhao, Fuhai, Wu, Keng, Cong, Hongliang, Wu, Yang, Yang, Phillip C., Chen, Keji, Zhang, Minzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118548/ https://www.ncbi.nlm.nih.gov/pubmed/27895696 http://dx.doi.org/10.1155/2016/7960503

Ejemplares similares

Traditional Chinese medicine, Danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study
por: Mao, Shuai, et al.
Publicado: (2016)

Efficacy and safety of Danlou tablets in traditional Chinese medicine for coronary heart disease: a systematic review and meta-analysis
por: Mao, WeiLi, et al.
Publicado: (2023)

Clinical and Epidemiological Investigation of TCM Syndromes of Patients with Coronary Heart Disease in China
por: Ren, Yi, et al.
Publicado: (2012)

PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury
por: Wei, Meng, et al.
Publicado: (2022)

Effects of Danlou tablet for the treatment of stable angina pectoris: A study protocol of a randomized, double-blind, and placebo-controlled clinical trial
por: Yang, Guang, et al.
Publicado: (2020)

Danlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis
por: Chen, Rui, et al.
Publicado: (2023)

Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multicentre, Nonrandomized Historically Controlled Trial
por: Wang, Lei, et al.
Publicado: (2012)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
por: Liu, Chunping, et al.
Publicado: (2021)

Danqi soft capsule prevents infarct border zone remodelling and reduces susceptibility to ventricular arrhythmias in post‐myocardial infarction rats
por: Ma, Shiyu, et al.
Publicado: (2019)

Danlou Tablet May Alleviate Vascular Injury Caused by Chronic Intermittent Hypoxia through Regulating FIH-1, HIF-1, and Angptl4
por: Rong, Yi, et al.
Publicado: (2022)

Danlou Tablet Activates Autophagy of Vascular Adventitial Fibroblasts Through PI3K/Akt/mTOR to Protect Cells From Damage Caused by Atherosclerosis
por: Wang, Li, et al.
Publicado: (2021)

Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis
por: Pan, Wenjun, et al.
Publicado: (2019)

Apocynum Tablet Protects against Cardiac Hypertrophy via Inhibiting AKT and ERK1/2 Phosphorylation after Pressure Overload
por: Qi, Jianyong, et al.
Publicado: (2014)

Effects of Yangxinshi tablet on exercise tolerance in patients with coronary heart disease: A protocol of randomized, double-blind, placebo-controlled, and multi-center trial
por: Zhang, Sisi, et al.
Publicado: (2020)

Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial
por: Wu, Xiaoping, et al.
Publicado: (2022)

Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences
por: Liu, Shaonan, et al.
Publicado: (2021)

Tongguan Capsule Mitigates Post-myocardial Infarction Remodeling by Promoting Autophagy and Inhibiting Apoptosis: Role of Sirt1
por: Mao, Shuai, et al.
Publicado: (2018)

The “L-Sandwich” Strategy for True Coronary Bifurcation Lesions: A Randomized Clinical Trial
por: Guo, Quan, et al.
Publicado: (2023)

Outcomes of Surgical Patch Angioplasty of The Coronary Artery for Diffuse Coronary Artery Disease
por: Li, Dong, et al.
Publicado: (2020)

Clinical Study for Safety Evaluation of GXN Tablets Combined with Aspirin in Long-Term Treatment of Coronary Heart Disease
por: Zi, Mingjie, et al.
Publicado: (2021)

Danhong Injection (a Traditional Chinese Patent Medicine) for Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
por: Liao, Pengda, et al.
Publicado: (2015)

Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
por: Ma, Shiyu, et al.
Publicado: (2018)

Prognostic Value of Asymmetric Dimethylarginine in Patients with Heart Failure: A Systematic Review and Meta-analysis
por: Pan, Wenjun, et al.
Publicado: (2020)

miR-941 as a promising biomarker for acute coronary syndrome
por: Bai, Ruina, et al.
Publicado: (2017)

Tongguan capsule ameliorates coronary artery stenosis in a 40-year-old woman
por: Ma, Huan, et al.
Publicado: (2015)

Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: protocol for systematic review and network meta-analysis
por: Liu, Shaonan, et al.
Publicado: (2017)

Impact of infection in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: insight from a multicentre observational cohort from China
por: Chen, Peng-Yuan, et al.
Publicado: (2020)

Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies
por: Zuo, Tian, et al.
Publicado: (2016)

Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice
por: Qi, Jianyong, et al.
Publicado: (2013)

Relationship of Glycated Hemoglobin A1c with All-Cause and Cardiovascular Mortality among Patients with Hypertension
por: Zeng, Ruixiang, et al.
Publicado: (2023)

Comparative effectiveness of six Chinese herb formulas for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and network meta-analysis
por: Liu, Shaonan, et al.
Publicado: (2019)

Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease
por: Wu, Song, et al.
Publicado: (2017)

Pharmacologic Management of Coronary Artery Ectasia
por: Khedr, Anwar, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Prior percutaneous coronary intervention and outcomes in patients after coronary artery bypass grafting: a meta-analysis of 308,284 patients
por: Zhang, Hongliang, et al.
Publicado: (2022)

Multimodality imaging of a hairpin-like coronary fistula between the right coronary artery and the coronary sinus
por: Peng, Yuan, et al.
Publicado: (2021)

Association of triglyceride–glucose index with coronary severity and mortality in patients on dialysis with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Acute Effects of Particulate Air Pollution on the Incidence of Coronary Heart Disease in Shanghai, China
por: Ye, Xiaofang, et al.
Publicado: (2016)

A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
por: Wu, Xiaoping, et al.
Publicado: (2022)

The first multicentre study on coronary anomalies in the Netherlands: MuSCAT
por: Koppel, C. J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtvn7stupvkkir3a9lpjl6edoe